Overview
Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
Status:
Completed
Completed
Trial end date:
2004-09-01
2004-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.Collaborator:
Otsuka America PharmaceuticalTreatments:
Aripiprazole
Criteria
Inclusion Criteria:- Primary diagnosis of idiopathic Parkinson's disease.
- Psychosis related to Parkinson's disease.
Exclusion Criteria:
- Psychosis present prior to diagnosis of Parkinson's disease.